https://feeds.newsfilecorp.com/company/8099 Latest news from Bright Minds Biosciences Inc. , as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Mon, 09 Mar 2026 20:58:02 -0400 https://www.newsfilecorp.com/images/newswire/customer-logos/8099.jpg https://feeds.newsfilecorp.com/company/8099 https://www.newsfilecorp.com/release/226772/Bright-Minds-is-Unaware-of-Any-Material-Changes Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - At the request of CIRO, Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") wishes to confirm that the Company's management is unaware of any material changes in the Company's operations that would account for the recent increase in market activity.About Bright MindsBright Minds is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain....<img src="https://api.newsfilecorp.com/newsinfo/226772/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Tue, 15 Oct 2024 21:09:00 -0400 en https://www.newsfilecorp.com/release/226772